[Immunohepatologic and clinical monitoring of neuramide therapy in acute viral hepatitis B]

Boll Ist Sieroter Milan. 1985;64(1):42-51.
[Article in Italian]

Abstract

The authors carried out a double blind therapeutic trial with neuramide in 20 drug addicts affected by acute type B anti-delta negative viral hepatitis. The H/S ratio together with the most important clinical and hepatological parameters seem to improve following treatment.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Monoclonal / immunology
  • Antimicrobial Cationic Peptides*
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Hepatitis B / drug therapy*
  • Hepatitis B Antibodies / analysis
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis B e Antigens / analysis
  • Humans
  • Immunoglobulin M / analysis
  • Killer Cells, Natural / immunology
  • Male
  • Peptides / therapeutic use*
  • Placebos
  • Substance-Related Disorders
  • T-Lymphocytes, Helper-Inducer / immunology
  • T-Lymphocytes, Regulatory / immunology

Substances

  • Antibodies, Monoclonal
  • Antimicrobial Cationic Peptides
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Immunoglobulin M
  • Peptides
  • Placebos
  • neuramide